JPMorgan Reiterates Overweight Rating on Phibro Animal Health Corp. (PAHC) Ahead of Q4 Print
JPMorgan analyst Ekaterina Knyazkova reiterated an Overweight rating and $58.00 price target on Phibro Animal Health Corp. (NASDAQ: PAHC).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
